Analysed INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) News Sources
Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
22-06-2026
yahoo.com
Innovent's Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second Half of 2026
25-06-2026
yahoo.com
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
30-06-2026
yahoo.com
Eli Lilly and Innovent agree Verzenios commercialisation deal in China
01-07-2026
pharmaceutical-technology.com
What is the current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is $44.11.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is $0.55.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is 1.2626%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is 74 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.